Clinical Trials in Los Angeles

Showing 4201-4220 of 12,794 trials

Effects of Biofeedback on Somatic Symptoms

NCT05120648

Biofeedback is a therapeutic paradigm that teaches patients how to gain awareness and control over previously unrecognized sympathetic changes such as body temperature, blood pressure, and heart rate. We propose to use a six session biofeedback protocol that includes heart-rate variability (HRV) biofeedback, respiration/relaxation training, and body temperature control to treat UCLA patients with chronic medical conditions (e.g. pulmonary, neurology) and somatic symptoms (pain, psychosomatic non-epileptic seizures, panic attacks, long-COVID symptoms). The aim of the study is to determine whether patients who complete a six-session biofeedback protocol report a decrease in somatic symptoms, and improvements in self-rated mental health (depression, anxiety, quality of life) after the program and at three-months follow-up. The investigators will also study whether these improvements are also related to reduced healthcare utilization.

Somatic Symptom

University of California, Los Angeles20 participantsStarted Sep 2021

Los Angeles, California, United States

COMPLETEDPhase 2< 1 mile

Study to Evaluate the Safety and Efficacy of Lenacapavir (GS-6207) in Combination With Other Antiretroviral Agents in People Living With HIV

NCT04143594

The primary objective of this study is to evaluate the efficacy of lenacapavir (formerly GS-6207) containing regimens in people living with human immunodeficiency virus (HIV) (PLWH).

HIV-1-infection

Gilead Sciences183 participantsStarted Nov 2019

Phoenix, Arizona, United States • Phoenix, Arizona, United States • Los Angeles, California, United States +50 more locations

Effects of Biofeedback on Somatic Symptoms

Study to Evaluate the Safety and Efficacy of Lenacapavir (GS-6207) in Combination With Other Antiretroviral Agents in People Living With HIV

Find Trials by Condition in Los Angeles

A Study to Learn About The Study Medicine (PF-07038124) In Patients With Mild To Moderate Atopic Dermatitis Or Mild To Severe Plaque Psoriasis.

Study of NGM707 As Monotherapy and in Combination with Pembrolizumab in Advanced or Metastatic Solid Tumor Malignancies

Randomized Global Phase 3 Study to Evaluate the Impact on NASH With Fibrosis of Obeticholic Acid Treatment

Safety, Tolerability, and Pharmacokinetics Study of MK-8189 in Participants With Schizophrenia and Healthy Participants (MK-8189-011)

Assessment of the Safety and Effectiveness of a Micro-RF Skin Treatment Device (nebulyft）

Health in Motion Pragmatic Clinical Trial - WRAPAROUND

CLN-0045: Safety, and Efficacy of OTX-TIC in Participants With Open Angle Glaucoma or Ocular Hypertension

Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy Trial of BNT141 in Patients With Unresectable or Metastatic CLDN18.2-positive Gastric, Pancreatic, Ovarian and Biliary Tract Tumors

Post-Market Study to Assess Outcomes of Patients Treated With AFX System Compared to Other EVAR Devices

Study of CD388 Subcutaneous Administration in Healthy Japanese Subjects

WHOOP ECG Software Performance Assessment Study

Ravulizumab in Thrombotic Microangiopathy Associated With a Trigger

Pharmacokinetic Drug-drug Interaction Study of Encorafenib and Binimetinib on Probe Drugs in Patients With BRAF V600-mutant Melanoma or Other Advanced Solid Tumors

The MOTION Study - Treatment of LSS With the MILD Procedure

Open-Label Extension Study of Trofinetide for Rett Syndrome

Safety and Tolerability of GTX-104 Compared with Oral Nimodipine in Patients with ASAH

A Comparison of an Investigational Dressing to Tegaderm Matrix Wound Dressing in the Management of Diabetic Foot Ulcers

Inspiring New Science In Guiding Healthcare in Turner Syndrome Registry